Prospective Multicenter Study on Mitral Annular Disjunction

Last updated: December 7, 2024
Sponsor: University Hospital of Ferrara
Overall Status: Active - Recruiting

Phase

N/A

Condition

Mitral Valve Regurgitation

Heart Valve Disease

Treatment

diagnostic flow

Clinical Study ID

NCT04916535
367/2021/Oss/AOUFe
  • Ages 18-65
  • All Genders

Study Summary

Observational cohort prospective multicenter study on patients with mitral annular disjunction (MAD). MAD is defined as a separation (≥1 mm) between the atrial wall-mitral valvular junction and the left ventricular free wall during end-systole

Eligibility Criteria

Inclusion

Inclusion criteria:

  • Subject aged ≥18 years and <65 years

  • Evidence of MAD during routine echocardiography clinically indicated by treatingphysician for any reason

  • Written informed consent

Exclusion

Exclusion criteria:

• Patient's refusal

Study Design

Total Participants: 200
Treatment Group(s): 1
Primary Treatment: diagnostic flow
Phase:
Study Start date:
June 03, 2021
Estimated Completion Date:
June 30, 2029

Study Description

Mitral annular disjunction (MAD) is a structural abnormality of the mitral annulus, defined as a separation (≥1 mm) between the atrial wall-mitral valvular junction and the left ventricular free wall during end-systole. This abnormality is significantly associated with the presence of mitral valve prolapse (MVP), but it can also be observed in normal hearts. MAD-related hypermobility of the mitral apparatus and the consequent posterior systolic curling determine a mechanical stress of the infero-basal wall and papillary muscle. This phenomenon leads to myocardial hypertrophy and fibrosis, creating an arrhythmogenic substrate and a source of electrical instability. For this reason, the analysis of left ventricle by cardiac magnetic resonance plays a pivotal role in the identification of predictors of fatal arrhythmic events, such as sudden cardiac death (SCD). Taking into account that MAD could be present without MVP, some studies analyzed the association between MAD and arrhythmic events. They showed that MAD itself is a risk marker of electrical instability supporting the existence of an emerging clinical entity: the MAD arrhythmic syndrome. An in deep analysis of MAD patients and their characteristics in terms of EKG, types of arrhythmia, echocardiographic parameters and cardiac magnetic resonance (CMR) data and long-term events is lacking.

The present study is ideated and conducted to fill this gap and collect information regarding management and outcome of patients with MAD

Connect with a study center

  • Cardiology Unit

    Bologna,
    Italy

    Active - Recruiting

  • University Hospital of Ferrara

    Ferrara, 44124
    Italy

    Active - Recruiting

  • Morgagni Hospital

    Forlì,
    Italy

    Active - Recruiting

  • Cardiology Unit

    Palermo,
    Italy

    Active - Recruiting

  • Santa Maria delle Croci Hospital

    Ravenna,
    Italy

    Active - Recruiting

  • Cardiology Unit

    Rimini,
    Italy

    Active - Recruiting

  • University Hospital fo Trieste

    Trieste,
    Italy

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.